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Introduction 
Hypertension (HTN) is a lifestyle disorder 
occurs due to faulty lifestyle and stressful psychological 
conditions with a low estimate of remission and 
recovery. The 2017 American College of Cardiology 
and American Heart Association (ACC/AHA) blood 
pressure guidelines recommended some striking 
changes in the diagnosis and management of 
hypertension (1). Diagnostic criteria of HTN are 
systolic blood pressure above 130 mm Hg and diastolic 
above 80 mm Hg (1). Hypertension is called as a silent 
ki l ler because major i ty pat ients (85%) are 
asymptomatic (2) and cause adverse effect to brain, 
kidney, heart and peripheral arteries over a period (3). 
Hypertension is precisely responsible for 57% of all 
stroke deaths and 24% of all coronary heart disease 
(CHD) deaths in India (4). About 26.4% of the world 
adult population in 2000 had hypertension and 29.2% 
were predicted to have this disorder by 2025 (5). In 
95% cases of the hypertension, the primary etiological 
factors are still unknown (6) but are presumed to be due 
to genetic and environmental factors (7). Although 
antihypertensive therapy certainly reduces the risk of 
cardiovascular and renal disease, but lifelong usage of 
antihypertensive drugs is associated with detrimental 
effects (8). Hence to attain and maintain good health, 
hypertensive patients are looking towards Ayurveda. 
In Ayurveda, there is no direct reference 
regarding this disease which completely resembles with 
hypertension. Many scholars had worked on 
hypertension and had given various nomenclature 
which can be correlated with hypertension such as 
Raktagatvata, Avruta Vata, Siragatvata, Dhamani 
Pratichaya, Vyana Prakopa, Raktamada etc (9) but 
none of these terms were universally accepted.  
In Ayurveda, the regulation of blood pressure is 
governed by the Tridoshas viz Vata (Prana and Vyana), 
Pitta (Sadhaka) and Kapha (Avalambaka), Dushya like 
Rasa, Rakta and Meda, with the proper functioning of 
Mana (mind) and Oja which are situated in heart and 
helps in circulation of blood. On the basis of strong 
resemblances between etiological factors (10), 
symptoms (11), involvement of Doshas and Dushya in 
the etiopathology and complication (12), it is believed 
Vata Dosha to be the main culprit. Hence, Essential 
Hypertension can be correlated with Vata Pradhana 
Tridoshaja Vyadhi. 
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Acharya Charaka has mentioned that if there is 
Bahudosha Avastha, then morbid toxins should be 
eliminated by the purificatory process (13). Virechana is 
mainly indicated in Pitta and Shonita predominant 
Vyadhi (14). As Pitta Dosha is having Asharaya-ashrayi 
Sambandha (mutual interdependence) with Rakta 
Dhatu, so Virechana is significantly beneficial in Rakta 
Dushtijanya Vyadhi (15). In Vatapradhana Vyadhi, 
Mridu Sanshodhana is the choice of treatment (16). 
Nitya Virechana is a type of Mridu Sanshodhana. There 
are many Virechana drugs described in Samhita. Among 
them, Trivrit is considered as Sukhavirechaka (17). So 
in this study, Trivrit Churna was selected for Nitya 
Virechana in the management of Stage 1 Essential 
Hypertension. 
Aims and Objectives 
To study the effect of Nitya Virechana with 
Trivrit Churna on Systolic and Diastolic blood pressure 
in Stage 1 Essential Hypertension. 
Materials and Methods 
A total 9 patients were registered for the study 
from the outpatient and inpatient of Department of 
Panchakarma, Mahatma Gandhi Ayurved College 
Hospital & Research Centre, Wardha, Maharashtra, 
India, who were newly diagnosed with Stage 1 Essential 
Hypertension. Informed consent was obtained from the 
patients before starting the intervention.  
Inclusion Criteria  
Newly diagnosed patients of Stage 1 Essential 
Hypertension i.e. SBP (130-139 mm Hg) or DBP (80-89 
mm Hg) of either sex between the age group of 30-60 
years were included for the study. 
Exclusion Criteria  
• Patients having Stage 2 Hypertension i.e. SBP (≥ 140 
mm Hg) or DBP (≥ 90 mm Hg). 
• Hypertension associated with cardio-vascular 
diseases, cerebro-vascular diseases, renal function 
impairment, hypothyroidism, diabetes mellitus 
(Type1/ Type 2/ GDM), Pregnant and lactating 
women. 
• Patients having Bleeding Hemorrhoids, Chronic 
Fissure-in-ano, Irritable Bowel Syndrome (IBS). 
Diagnostic Criteria 
The diagnostic criteria of hypertension were 
taken from American College of Cardiology and 
American Heart Association (ACC/AHA) blood 
pressure guidelines 2017 (1) which is shown in table 1. 
Table 1: Diagnostic Criteria of Hypertension (ACC/
AHA blood pressure guidelines) 
Investigations for screening  
All patients were screened through history and 
routine investigations. Hemoglobin percentage, Fasting 
Blood Sugar, Total Cholesterol, Triglyceride, Serum 
Sodium, Serum Potassium, Serum Creatinine and 
Electro Cardio Graph. These investigations were carried 
out before starting the intervention to exclude any other 
pathology related to exclusion criteria. 
Treatment  
Nitya Virechana with 10 gms of Trivrit Churna 
was given with lukewarm water at empty stomach 
around 6 a.m. for consecutive 15 days. 
Study Duration  
Initially treatment lasted for 15 days and follow 
up period after 15 days. The total study duration is 30 
days. 
Method of administration  
The patients were briefed to do their routine 
work. The interventional medicine is advised to take 
after proper digestion of previously ingested food. The 
dose of Trivrit Churna administered is 10 grams with 
lukewarm water at 6 am IST. Instructed them to note 
down the proper evacuation of mala or any complaints 
regarding abdominal discomfort for 15 days of the 
study. 
Diet and Restrictions  
Patients were advised to take normal diet free 
from excessive salty, oily, sour items etc. and were also 
advised not to indulge in Ashtamahadoshakara Varjya 
Vishayas l ike Uchhabhashya ( loud speech), 
Rathakshobha (travelling), Atichakramana (excessive 
walking), Atiasana (sedentary habit), Ajirna (intake of 
food during indigestion), Ahitabhojana (faulty dietary 
habits), Diwaswapna (daysleep) and Maithuna (sexual 
intercourse). 
Blood 
Pressure 
Category
Systolic 
Blood 
Pressure
Diastolic 
Blood 
Pressure
Normal < 120 mm Hg And < 80 mm Hg
Elevated 120-129 mm 
Hg
And < 80 mm Hg
Stage 1 
Hypertension
130-139 mm 
Hg
Or 80-89 mm Hg
Stage 2 
Hypertension
≥ 140 mm Hg Or ≥ 90 mm Hg
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Assessment Criteria 
Subjective Criteria: Shiroruk, Klama, Bhrama and Anidra were considered as subjective parameters having grades 0 
to 4 are shown in table 2. 
Table 2: Assessment criteria for subjective parameters 
Objective Criteria 
1. Systolic blood pressure 
2. Diastolic blood pressure 
Assessment of Effect of Therapy 
Assessment was carried out three times, one before the treatment, second after the treatment and third after the 
end of follow-up period. The data were statistically analyzed using Chi-square and paired t test. If p<0.05 is 
considered as statistically significant result. Total effect of therapy was assessed on the basis of percentage of relief in 
subjective parameters. 
1.Controlled   100% relief in complaints 
2.Marked relief  ≥ 75% relief in complaints 
3.Moderate relief  ≥  50-74% relief in complaints 
4.Mild relief  ≥  25-49% relief in complaints 
5.No relief  < 25% relief in complaints 
Observations 
The maximum number of patients were males (66.6%), were belonged to 50-60 age groups (55.5%), were 
Hindus (77.7%), middle class category socioeconomic status (55.5%). Distribution according to occupational status, it 
was observed that majority patients were belonging to service class (44.4%). Mean Systolic and Diastolic blood 
pressure was 139.53 mm Hg and 88.33 mm Hg respectively. Majority of patients had family history (77.7%). The 
maximum number of patients had mixed diet (55.5%) and Lavana Rasatmaka Ahara (66.6%). Majority patients had 
Vatapittaja Prakriti (44.4%), Krura Koshta (66.6%), Vishamagni (77.7%), Asamyak Malapravrutti (88.8%) and Saam 
Jivha (77.7%). It was observed that majority of hypertensive patients were addicted to alcohol consumption (44.4%) 
and had stress-full lifestyle (66.6%). As per subjective parameters, it was observed that Shiroruk was observed in 1, 5 
and 3 patients having Grade 2, 3 and 4 respectively. After follow up period, out of these 9 patients, 1 patient got 
relieved of the symptoms and remaining 5, 2 and 1 patient got significant reduction in the intensity of symptom with 
Grade 1, 2 and 3 respectively. Klama was observed in 1, 3 and 5 patients with Grade 2, 3 and 4. After follow up 
period, significant reduction was observed in the severity of symptom in 1, 4 and 4 patients having Grade 0, 1 and 2. 
Bhrama was observed in 2, 2, 3 and 2 patients having Grade 1, 2, 3 and 4 respectively. Out of these 9 patients, 3 
S.No Subjective 
Criteria
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4
1 Shiroruk
(Headache)
Nil Rarely headache 
relieves without 
medication
Headache 
relieves by rest; 
doesn’t disturb 
daily activities
Severe headache 
disturbs daily 
activities requires 
medication
Continuous/ severe 
headache disturbs 
sleep and daily 
activities and also not 
managed by the 
medication
2 Klama 
(Fatigue)
Nil Rarely feeling of 
tiredness without 
any exertion
Rarely feeling of 
tiredness without 
any exertion with 
inability in 
concentration
Frequently feeling 
of tiredness 
without any 
exertion with 
inability in 
concentration
Continuous feeling of 
tiredness without any 
exertion with 
inability in 
concentration
3 Bhrama
(Giddiness)
Nil Rarely Bhrama 
for some 
movement 
during change of 
posture
Often for some 
movement during 
change of posture
Often for each 
movement even in 
lying condition 
also
Patient unable to 
hold himself without 
any support
4 Anidra
(Disturbed 
sleep/
Insomnia)
Sound 
sleep
Disturbed sleep, 
wakes-up 1-2 
times a night 
(Khandita 
Nidra)
Difficult onset 
sleep remains 
disturbed in night
(Alpa Nidra)
Very less sleep, in 
small intervals and 
makes patient 
irritable
(Atialpa Nidra)
Unable to sleep 
without medicine 
(Anidra)
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patients got relieved of the symptoms and remaining 4 and 2 patients got significant reduction in the intensity of 
symptom with Grade 1 and 2 respectively after follow-up period. On context of Anidra, before intervention, there 
were 3, 2 and 4 patients were having Grade 2, 3 and 4 which got significant reduction in the intensity of symptom with 
2, 5 and 2 patients having Grade 0, 1 and 2 respectively after follow-up period [Table 3]. The mean values of SBP 
before treatment was 139.53 ± 2.83 which got significantly reduced to 131.14 ± 3.05 after intervention and after 
follow-up period, it again significantly reduced to 129.58 ± 2.96. The mean values of DBP before treatment was 88.33 
± 2.69 which significantly reduced to 80.17 ± 2.75 after intervention and after follow-up period, it again reduced to 
79.83 ± 2.55 [Table 4]. Nitya Virechana is not a proper Shodhana procedure, so the assessment of Vega is not 
applicable and also it was difficult to count the Vega of each patient for 15 days, but on average it was observed that 
Krura Koshta patients had 1-2 Vegas, whereas 2-3 Vegas was observed in Mrudu Koshta patients. 
Table 3: Assessment of effect of therapy on Subjective parameters 
Table 4: Assessment of effect of therapy on Objective parameters 
Results 
Statistically significant results (p<0.05) were 
found which shows that Nitya Virechana with Trivrit 
Churna was statistically effective in reducing the 
intensity of symptoms of hypertension. The results 
obtained were highly significant (p<0.0001) in objective 
parameters which shows that Nitya Virechana with 
Trivrit Churna was highly effective in reducing the 
Systolic and Diastolic blood pressure even after follow 
up period. On summarizing the total effect of therapy, 
marked relief was found in 3 patients (33.3%) and 
moderate relief was found in 6 patients (66.7%) [Table 
5]. 
Table 5: Assessment of total effect of therapy on the 
basis of percentage of relief in subjective parameters 
S.No. Assessment Parameter Grade Before T/t After T/t
After 
Follow-up
χ2-value
After FU P value
1 Shiroruk
Grade 0 0(0%) 0(0%) 1(11.1%) 16.76 <0.05, S
Grade 1 0(0%) 3(33.4%) 5(55.6%)
Grade 2 1(11.1%) 4(44.4%) 2(22.2%)
Grade 3 5(55.5%) 2(22.2%) 1(11.1%)
Grade 4 3(33.4%) 0(0%) 0(0%)
2 Klama
Grade 0 0(0%) 0(0%) 1(11.2%) 11.89 <0.05, S
Grade 1 0(0%) 2(22.2%) 4(44.4%)
Grade 2 1(11.1%) 3(33.4%) 4(44.4%)
Grade 3 3(33.4%) 4(44.4%) 0(0%)
Grade 4 5(55.5%) 0(0%) 0(0%)
3 Bhrama
Grade 0 0(0%) 2(22.2%) 3(33.4%) 10.68 <0.05, S
Grade 1 2(22.2%) 3(33.4%) 4(44.4%)
Grade 2 2(22.2%) 2(22.2%) 2(22.2%)
Grade 3 3(33.4%) 2(22.2%) 0(0%)
Grade 4 2(22.2%) 0(0%) 0(0%)
4 Anidra
Grade 0 0(0%) 0(0%) 2(22.2%) 15.18 <0.05, S
Grade 1 0(0%) 3(33.3%) 5(55.6%)
Grade 2 3(33.4%) 3(33.3%) 2(22.2%)
Grade 3 2(22.2%) 3(33.3%) 0(0%)
Grade 4 4(44.4%) 0(0%) 0(0%)
S. No. Assessment Parameter
Before T/t
(mean ± SD)
After T/t
(mean ± SD)
After Follow-up
(mean ± SD)
t value 
After FU P value
1 Systolic Blood Pressure (SBP) 139.53 ± 2.83 131.14 ± 3.05 129.58 ± 2.96 12.69 0.0001, HS
2 Diastolic Blood Pressure (DBP) 88.33 ± 2.69 80.17 ± 2.75 79.83 ± 2.55 10.89 0.0001, HS
Total effect of 
therapy Range % of relief
Controlled 100% 0(0%)
Marked Relief ≥75% 3(33.3%)
Moderate Relief ≥50-74% 6(66.7%)
Mild Relief ≥25-49% 0(0%)
No Relief <25% 0(0%)
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Discussion 
Hypertension is one among the most alarming 
health disorder in today’s time period. The lateral 
pressure exerted by blood on the lateral walls of blood 
vessels over and above the atmospheric pressure is said 
to be hypertension. In Ayurveda, there is no direct 
references regarding hypertension and as per Ayurvedic 
principles, in case of unknown disease, the physician 
should try to interpret the features of the disease 
through the involvement of Dosha, Dushya and its 
etiological factors involved in the pathogenesis of the 
disease and treat accordingly (18). Blood Pressure is the 
outcome of many physiological activities which is 
regulated by the Tridoshas viz Vata (Prana and Vyana), 
Pitta (Sadhaka), and Kapha (Avalambaka) Doshas, 
Dushyas like Rasa, Rakta and Meda, with the proper 
functioning of Mana and Oja which are situated in heart 
and helps in pumping of blood (19). On the basis of 
involvement of these factors, hypertension is said to be 
Vata Pradhana Tridoshaja Vyadhi.  
Trivrit Churna predominantly has Madhura, 
Katu, Tikta, Kashaya Rasa, acts as Pittakaphahara and 
h a s S u k h a v i re c h a k a , A n u l o m a n a , H r i d y a , 
Raktashodhaka, Amapachaka, Vedanasthapana etc. 
properties and are indicated in Hridroga, Raktavikara, 
Jwara, Pleeha-yakruta Vyadhi etc (20). The chemical 
constituents of Trivrit comprises of Turpethinic acids, α 
and β-turpethin, lupeol, b-sitosterol, botulin etc (21). 
The laxative effect of Trivrit is mainly due to the 
presence of turpethin (22). This fundamental constituent 
is believed to work on mysentric plexus and increase 
peristaltic movements in the body, thus acts as a 
laxative. Operculina turpethum exhibit analgesic, 
carminative, anti-inflammatory, antioxidant, hepato-
protective, immunomodulatory and hydragogue 
activities (23). When administered as laxative helps in 
alleviating the symptoms of hypertension by initiating 
the excretion of sodium and reducing vascular 
resistance. 
Mridu Sanshodhana has been mentioned as the 
line of treatment of Vata Vyadhi. Nitya Virechana is a 
type of Mridu Sanshodhana. The probable mode of 
action of Nitya Virechana with Trivrit Churna can be 
understood by the dominant pharmacodynamics which 
helps in removing obstruction (Margavarodha) and 
eliminates the excess morbid toxic materials 
(Kledamsha) through Adhobhaga by the predominance 
of Jala and Prithvi Mahabhutas. Thereby it helps in 
pacifying Kapha and Pitta Doshas which altogether has 
its effect on Rakta due to Ashraya-ashrayi Sambandha 
and regulates Vata Dosha by its Anulomana action and 
ultimately balances the Tridosha. Thus Nitya Virechana 
acts either by hyper osmotic action or by reducing fluid 
electrolyte retention in the blood helps in expulsion of 
morbid Doshas from the body in less quantity and 
thereby reduces the total volume of Rasa and Rakta and 
maintaining the electrolyte balance and ultimately 
decreased blood pressure. Hence, we can conclude that 
Nitya Virechana with Trivrit Churna acts by 
Pittakaphahara, Sukhavirechaka, Anulomana and 
Raktashodhaka properties, which helps in maintaining 
osmotic pressure, thereby regularize Tridosha and 
reduces hypertension. 
Conclusion 
Hypertension is a common disorder of present 
era. Essential Hypertension is a psychosomatic 
hemodynamic disorder which is well explained in 
modern medicine can be correlated with Vata Pradhana 
Tridoshaja Vyadhi in Ayurveda based on the similarities 
in etiological factors, clinical features, complications 
etc. Statistically significant reduction in clinical 
symptomatology of hypertension and significant 
improvement was found in Systolic and Diastolic blood 
pressure. From the outcomes, we can conclude that 
Nitya Virechana with Trivrit Churna is effective to 
reduce Systolic and Diastolic blood pressure in Stage 1 
Essential Hypertension. In this study none of the 
patients had developed any adverse effects during the 
course of treatment. The sample size was small and the 
study duration was too short to draw exact conclusion, 
thus the study with large sample and optimum duration 
should provide more improvement.   
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